AdvanDx's Series C Round

AdvanDx raised a round of funding on August 24, 2009.

AdvanDx is a provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. The company's mission is to improve anti…

Articles about AdvanDx's Series C Round: